Insulin Purification via High-Pressure Cation Exchange and Reverse Phase Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying insulin and insulin analogs are inadequate in achieving high yield and pharmaceutically acceptable purity, particularly in removing impurities and properly folding insulin molecules from enzymatic cleavage reactions.
Innovation Solution
A two-step chromatographic process involving acid-stable cation exchange chromatography followed by reverse phase high performance liquid chromatography, both performed at elevated temperatures and in the presence of water miscible organic modifiers, to isolate properly folded insulin or insulin analogs with high purity and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional ion-exchange chromatography is performed at atmospheric or medium pressure, then the process is simpler to operate, but the manufacturing precision and purity of insulin are insufficient
Solution Approach 1:
The patent applies high pressure (1.1-40 MPa) and elevated temperature (30-50°C) parameters to the cation exchange chromatography process, transforming conventional low-pressure conditions into a high-pressure system that achieves superior insulin purity (99% or greater) while maintaining operational feasibility through automated high-pressure liquid chromatography equipment
Solution Approach 2:
The patent employs a two-step composite chromatography process combining cation exchange chromatography (first step) with reverse phase chromatography (second step). This composite approach uses different chromatographic mechanisms in sequence, where the cation exchange step removes acidic impurities and the reverse phase step achieves final purification, resulting in cumulative purity enhancement that neither method could achieve alone
2Manufacturing precision
If multiple chromatographic steps are performed to achieve high purity, then the purity of insulin increases, but the productivity and time consumption increase
Solution Approach 1:
The patent implements a continuous two-step chromatographic process where the effluent from the cation exchange column is directly fed into the reverse phase column without intermediate handling or storage. This continuous operation eliminates idle time between steps, maintains constant flow rates, and ensures that the purification process runs efficiently from start to finish, achieving 99% purity with minimal time loss
Solution Approach 2:
The patent divides the purification process into two distinct functional segments: cation exchange chromatography for removing acidic impurities and reverse phase chromatography for final purification. Each segment is optimized for its specific function and can be operated independently, allowing for flexible process control and the ability to optimize each step separately for both purity and productivity
3Productivity
If conventional refolding and purification methods are used, then the process is simpler to implement, but the yield of properly folded insulin is insufficient
Solution Approach 1:
The patent utilizes elevated temperature (30-50°C) during both cation exchange and reverse phase chromatography steps, which enhances the solubility and conformational stability of insulin molecules. This temperature parameter optimization promotes proper folding of insulin during purification, increasing the yield of correctly folded, active insulin while the automated high-pressure system manages the process complexity
Solution Approach 2:
The patent uses water-miscible organic modifiers (such as acetonitrile or methanol) as intermediary substances in both chromatographic steps. These modifiers facilitate the interaction between insulin and the chromatography media, improve insulin solubility and folding, and enable efficient separation of insulin from impurities. The organic modifiers act as mediators that enhance the purification efficiency without requiring complex additional equipment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves a combined yield of 65% or greater and a purity of 99% or greater for isolated insulin or insulin analogs, effectively removing impurities and ensuring proper folding.
Implementation Method 1
high-pressure liquid chromatography with an acidic cation exchange medium
Implementation Method 2
reverse phase chromatography performed in the presence of a water miscible organic modifier and at an elevated temperature
Data Source
AI summary
A process is described for purifying insulin and insulin analogs that comprises high-pressure liquid chromatography with an acidic cation exchange medium performed in the presence of a water miscible organic modifier and at an elevated temperature followed by reverse phase chromatography performed in the presence of a water miscible organic modifier and at an elevated temperature.